Evidence map›Paper›PMID 37700112›Full record

ArticleClinical and experimental medicine2023

Early mortality in German patients with lung cancer: risk factors associated with 30-and 60-day mortality.

Amanda Tufman, Sophie Schneiderbauer, Julia Walter, Blerina Resuli, Diego Kauffmann-Guerrero, Carlo Mümmler, Pontus Mertsch, Jeremias Götschke, Julia Kovács, Farkhad Manapov and 6 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Amanda TufmanDepartment of Medicine V, University Hospital, LMU Munich, Munich, Germany.
Sophie SchneiderbauerComprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.
Julia WalterDepartment of Medicine V, University Hospital, LMU Munich, Munich, Germany. Julia.Walter@med.uni-muenchen.de.
Blerina ResuliDepartment of Medicine V, University Hospital, LMU Munich, Munich, Germany.
Diego Kauffmann-GuerreroDepartment of Medicine V, University Hospital, LMU Munich, Munich, Germany.
Carlo MümmlerDepartment of Medicine V, University Hospital, LMU Munich, Munich, Germany.
Pontus MertschDepartment of Medicine V, University Hospital, LMU Munich, Munich, Germany.
Jeremias GötschkeDepartment of Medicine V, University Hospital, LMU Munich, Munich, Germany.
Julia KovácsDepartment of Thoracic Surgery Munich, University Hospital, LMU Munich, Munich, Germany.
Farkhad ManapovDepartment of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Christian SchneiderDepartment of Thoracic Surgery Munich, University Hospital, LMU Munich, Munich, Germany.
Laura SellmerDepartment of Medicine V, University Hospital, LMU Munich, Munich, Germany.
Paola ArnoldDepartment of Medicine V, University Hospital, LMU Munich, Munich, Germany.
Volker HeinemannComprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.
Jürgen BehrDepartment of Medicine V, University Hospital, LMU Munich, Munich, Germany.
Daniel NassehComprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany.
LMU Klinikum · DELudwig-Maximilians-Universität München · DEGerman Center for Lung Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite therapeutic advances, early mortality in lung cancer is still prevalent. In this study, we aimed to assess risk factors for 30- and 60-day mortality in German lung cancer patients. In this retrospective cross-sectional analysis, we used data of lung cancer patients treated at LMU Hospital Munich between 2015 and 2019. We categorized patients into 30-day mortality, 60 day-mortality, and longer survival. We used Student's t-test and ANOVA to compare means and Chi

Indexed as

Lung NeoplasmsCross-Sectional StudiesFemaleHumansRetrospective StudiesRisk FactorsWeight LossBronchial tumorsPremature deathShort survivalThoracic cancer

Identifiers

PMID37700112
PMCPMC10725334
OpenAlexW4386632327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.